Bruker, the manufacturer of scientific instruments for molecular and materials research, diagnostics and industry based in the US State of Massachusetts, has finalized the acquisition of Chemspeed Technologies AG. As the company has now announced, this takeover of the global specialists in lab automation from the canton of Basel-Landschaft, news of which first broke in January 2024, marks a significant milestone in its expansion plans.
“We are excited about the opportunities this acquisition brings, and we warmly welcome the excellent Chemspeed team to Bruker”, comments Bernd Gleixner, President of the new Automation Division at Bruker BioSpin and newly appointed Managing Director of Chemspeed. “Going forward, Chemspeed will continue to operate as a vendor-agnostic, standalone business within Bruker, maintaining its commitment to industry-leading automated laboratory solutions and customer service”, he adds.
As part of Bruker, Chemspeed is expected to be near break-even across the remaining three quarters of 2024 with sales of approximately 10 million US dollars per quarter. For the future, the company expects Chemspeed to achieve organic sales growth in the high single-digit to low double-digit range, in addition to steady, significant margin growth.
